Ring-Expanded (“Fat”) Nucleosides as Broad-Spectrum Anticancer and Antiviral Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
2
Page:
1093-1109
Author(s):
Ramachandra S. Hosmane
Monoclonal Antibodies as a Tool for Structure-Function Studies of the MDR1-P-Glycoprotein
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
513-530
Author(s):
M. Cianfriglia, C. Cenciarelli, S. Barca, M. Tombesi, M. Flego and M. L. Dupuis
Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1809-1814
Author(s):
Donald A. Podoloff
Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1827-1836
Author(s):
Jay Blum, Hirsch Handmaker and Neal A. Rinne
Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1723-1734
Author(s):
Shazib Pervaiz
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman
Tropism-Modified Adenoviral and Adeno-Associated Viral Vectors for Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
273-293
Author(s):
Stuart A. Nicklin and Andrew H. Baker
Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Journal:
Current Gene Therapy
Volume:
2
Page:
307-322
Author(s):
Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers
Polycistronic Viral Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
355-378
Author(s):
P. de Felipe
Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
379-392
Author(s):
O. Mazda